Company Analysis JD Health International Inc.
1. Summary
Advantages
- The stock's return over the last year (63.51%) is higher than the sector average (18.4%).
- The company's current efficiency (ROE=7.36%) is higher than the sector average (ROE=-5.11%)
Disadvantages
- Price (57.8 HK$) is higher than fair price (21.94 HK$)
- Dividends (0%) are below the sector average (1.61%).
- Current debt level 0.3625% has increased over 5 years from 0.0166%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| JD Health International Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 4.1% | -1.2% | 3.3% |
| 90 days | -4.8% | -33.1% | -0.9% |
| 1 year | 63.5% | 18.4% | 35.7% |
6618 vs Sector: JD Health International Inc. has outperformed the "Healthcare" sector by 45.11% over the past year.
6618 vs Market: JD Health International Inc. has outperformed the market by 27.84% over the past year.
Stable price: 6618 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 6618 with weekly volatility of 1.22% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (57.8 HK$) is higher than the fair price (21.94 HK$).
Price is higher than fair: The current price (57.8 HK$) is 62% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (21.45) is higher than that of the sector as a whole (-28.02).
P/E vs Market: The company's P/E (21.45) is lower than that of the market as a whole (45.19).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.52) is lower than that of the sector as a whole (3.04).
P/BV vs Market: The company's P/BV (1.52) is lower than that of the market as a whole (6.04).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (1.54) is lower than that of the sector as a whole (54.93).
P/S vs Market: The company's P/S indicator (1.54) is lower than that of the market as a whole (20.59).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (47.53) is higher than that of the sector as a whole (29.1).
EV/Ebitda vs Market: The company's EV/Ebitda (47.53) is higher than that of the market as a whole (37.54).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -91.54% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-91.54%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.81%).
6.4. ROE
ROE vs Sector: The company's ROE (7.36%) is higher than that of the sector as a whole (-5.11%).
ROE vs Market: The company's ROE (7.36%) is higher than that of the market as a whole (2.62%).
6.6. ROA
ROA vs Sector: The company's ROA (5.68%) is higher than that of the sector as a whole (0.2787%).
ROA vs Market: The company's ROA (5.68%) is higher than that of the market as a whole (2.7%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (13.72%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.61%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
